Drugs for treatment of kidney cancer

Evaluating the effectiveness of treatment for kidney cancer. Side effects of therapy.

Criteria for evaluating the effectiveness of the drug: RECIST? Choi?

Common side effects of therapy for kidney cancer. The effects of targeted therapies on the cardiovascular system

Targeted drugs and haemostasis

Nesvetlokletochnogo treatment for kidney cancer

Alternative modes and drug regimens for renal cell carcinoma –

Treatment of elderly patients

 

The situation in Russia

A new classification of renal cell carcinoma TNM

Diagnosis of renal cancer

Surgical treatment of kidney cancer

Prognostic model for kidney cancer

Adjuvant therapy for kidney cancer

Diskussion: The surgical and adjuvant treatment

Metastases of renal cancer in the bone

Surgical treatment of metastatic renal cell carcinoma

New in the medicinal treatment of metastatic renal cell carcinoma

VHL syndrome and renal cell carcinoma

The stability problem for kidney cancer targeted therapy

Cytoreductive nephrectomy value at the present stage

Drug treatment of metastatic renal cell carcinoma

Resistance to targeted therapy

Locally advanced RCC

Papillary renal cell carcinoma

New agents on the horizon

Small kidney tumor

 

Ablation

Treatment of particular groups of patients with metastatic RCC

Unterkunft:

Stay in the heart of the Moscow at a hotel specially discounted for attendees ( klicken Sie hier ).

for group discounts please contact us by email: [email protected]

Flüge:

From Europe to Russia from 50 Euro ( Ein Weg) : http://wizzair.com/?language=EN

Fragen

Kontaktieren Sie NBScience’s

Abteilung Bildung/Konferenzen:

Tel: +3.8044.233.2770

[email protected]

 

 

Informationsanfrage per WhatsApp: +447778936902